Puerto Rico Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 19 (86% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 6,452
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 99.94%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 159
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 100.00%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 0.06% 0.00%
White, Hispanic/Latino Patients 47.09% 49.69%
Black/African American, Non-Hispanic/Latino Patients 0.02% 0.00%
Black/African American, Hispanic/Latino Patients 6.28% 8.81%
Asian Patients3 0.00% 0.00%
American Indian/Alaska Native Patients3 0.03% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.00%
Patients with More than one race3 29.34% 30.19%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 16.96% 11.32%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.00% 0.00%
Unreported/Refused to Report Race and Ethnicity 0.23% 0.00%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,594
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 99.81%
COVID-19 Immunization Series Completed 5,434
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 100.00%
COVID-19 Immunization Series Additional 728
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 100.00%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 0.19% 0.00% 0.00%
White, Hispanic/Latino Patients 43.41% 45.05% 28.16%
Black/African American, Non-Hispanic/Latino Patients 0.00% 0.00% 0.00%
Black/African American, Hispanic/Latino Patients 6.34% 5.23% 1.10%
Asian Patients3 0.00% 0.00% 0.00%
American Indian/Alaska Native Patients3 0.06% 0.00% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.00% 0.00%
Patients with More than one race3 41.22% 40.23% 52.75%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 8.78% 9.37% 17.99%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.00% 0.00% 0.00%
Unreported/Refused to Report Race and Ethnicity 0.00% 0.13% 0.00%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 26.32%
1 to 24 Hours 36.84%
More Than 24 Hours 36.84%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 15.79%
Vaccine confidence 0.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 15.79%
None 68.42%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 83.42%
Average Percent of Health Center Visits Conducted Virtually 19.21%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 26.32%
Number of Mobile Van Sites 5
Number of Pop-up Clinics 31
Number of School-Based Vaccination Sites 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 5.26%
Refer patients to another organization that provides monoclonal antibody therapies 42.11%
None 52.63%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 21.05%
Patient awareness/education 5.26%
Staffing capacity 0.00%
Therapy administration/onsite logistics 15.79%
Other 10.53%
None 47.37%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021